Sildenafil 1A Pharma 25 mg, tabletten

Država: Nizozemska

Jezik: nizozemski

Izvor: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

Kupi sada

Uputa o lijeku Uputa o lijeku (PIL)
21-09-2022
Svojstava lijeka Svojstava lijeka (SPC)
24-08-2022

Aktivni sastojci:

SILDENAFILCITRAAT 35,1 mg/stuk SAMENSTELLING overeenkomend met ; SILDENAFIL 25 mg/stuk

Dostupno od:

1A Pharma GmbH Keltenring 1 + 3 82041 OBERHACHING (DUITSLAND)

ATC koda:

G04BE03

INN (International ime):

SILDENAFILCITRAAT 35,1 mg/stuk SAMENSTELLING overeenkomend met ; SILDENAFIL 25 mg/stuk

Farmaceutski oblik:

Tablet

Sastav:

CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341) ; CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; COPOVIDON (E 1208) ; CROSCARMELLOSE NATRIUM (E 468) ; INDIGOKARMIJN ALUMINIUMLAK (E 132) ; MAGNESIUMSTEARAAT (E 470b) ; SACCHAROIDE NATRIUM X-WATER (E 954), CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; COPOVIDON ; CROSCARMELLOSE NATRIUM (E 468) ; INDIGOKARMIJN ALUMINIUMLAK (E 132) ; MAGNESIUMSTEARAAT (E 470b) ; SACCHAROIDE NATRIUM X-WATER (E 954), CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; COPOVIDON ; CROSCARMELLOSE NATRIUM (E 468) ; INDIGOKARMIJN ALUMINIUMLAK (E 132) ; MAGNESIUMSTEARAAT (E 470b) ; SACCHAROIDE NATRIUM X-WATER (E 954),

Administracija rute:

Oraal gebruik

Područje terapije:

Sildenafil

Proizvod sažetak:

Hulpstoffen: CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341); CELLULOSE, MICROKRISTALLIJN (E 460); COPOVIDON; CROSCARMELLOSE NATRIUM (E 468); INDIGOKARMIJN ALUMINIUMLAK (E 132); MAGNESIUMSTEARAAT (E 470b); SACCHAROIDE NATRIUM 0-WATER (E 954);

Datum autorizacije:

1900-01-01

Uputa o lijeku

                                1A Pharma GmbH
Page 1
Sildenafil 1A Pharma 25/50/100 mg, tabletten
RVG 103576-78-80
1313-v15
1.3.1.3 Package Leaflet
Juni 2022
BIJSLUITER: INFORMATIE VOOR DE PATIËNT
SILDENAFIL 1A PHARMA 25 MG, TABLETTEN
SILDENAFIL 1A PHARMA 50 MG, TABLETTEN
SILDENAFIL 1A PHARMA 100 MG, TABLETTEN
sildenafil
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What [nationally completed name] is and what it is used for
2.
What you need to know before you take [nationally completed name]
3.
How to take [nationally completed name]
4.
Possible side effects
5.
How to store [nationally completed name]
6.
Contents of the pack and other information
1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR
[nationally completed name] contains the active substance sildenafil
which belongs to a group of
medicines called phosphodiesterase type 5 (PDE5) inhibitors. It works
by helping to relax the blood
vessels in your penis, allowing blood to flow into your penis when you
get sexually excited.
[nationally completed name] will only help you to get an erection if
you are sexually stimulated.
[nationally completed name] is a treatment for adult men with erectile
dysfunction, sometimes
known as impotence. This is when a man cannot get, or keep a hard,
erect penis suitable for sexual
activity.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE [NATIONALLY COMPLETED NAME]
DO NOT TAKE [NATIONALLY COMPLETED NAME]
-
if you are allergic to sildenafil or any of the other ingredients of
this medicine (listed in section 6).
-
if you are
                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                1A Pharma GmbH
Page 1
Sildenafil 1A Pharma 25/50/100 mg, tabletten
RVG 103576-78-80
1311-v14
1.3.1.1 Summary of Product Characteristics
Juni 2022
1. NAAM VAN HET GENEESMIDDEL
Sildenafil 1A Pharma 25 mg, tabletten
Sildenafil 1A Pharma 50 mg, tabletten
Sildenafil 1A Pharma 100 mg, tabletten
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
[nationally completed name] 25 mg tablets
Each tablet contains 25 mg of sildenafil (as citrate).
[nationally completed name] 50 mg tablets
Each tablet contains 50 mg of sildenafil (as citrate).
[nationally completed name] 75 mg tablets
Each tablet contains 75 mg of sildenafil (as citrate).
[nationally completed name] 100 mg tablets
Each tablet contains 100 mg of sildenafil (as citrate).
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Tablet
[nationally completed name] 25 mg tablet is a light blue, round,
slightly dotted tablet with breaking
notch on one side and debossment “25” on the other side.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
[nationally completed name] 50 mg tablet is a light blue, round,
slightly dotted tablet with cross
breaking notch on one side and debossment “50” on the other side.
The tablet can be divided into four equal doses.
Only intake of the whole tablet or concomitant intake of two quarters
is covered by posology.
[nationally completed name] 75 mg tablet is a light blue, round,
slightly dotted tablet with breaking
notch (divisible in 3 parts) on both sides and debossment “75” on
one side.
The tablet can be divided into three equal doses.
[nationally completed name] 100 mg tablet is a light blue, round,
slightly dotted tablet with cross
breaking notch on both sides and debossment “100” on one side.
The tablet can be divided into four equal doses.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Sildenafil is indicated in adult men with erectile dysfunction, which
is the inability to achieve or
maintain a penile erection sufficient for satisfactory sexu
                                
                                Pročitajte cijeli dokument